Stay updated with breaking news from Improving Global Outcome. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In our previous column, we presented evidence of the harmful effects of the excessive amount of protein that is usually part of the standard animal-based diet that most of our people now consume. In this column, we will focus on another harmful effect of an animal-based diet that typically includ...
The update includes a recommended triple therapy with belimumab as a first line treatment for class III or IV lupus nephritis following the approvals of belimumab and voclosporin.
SEOUL, South Korea--(BUSINESS WIRE)--A clinical-staged proprietary platform technology biotech company Genexine (KQ 095700, CEO Neil Warma) and its Asian regional partner, KG Bio unveiled the interim results of phase 3 clinical trial of GX-E4 (Efepoetin alfa), a candidate for CKD (Chronic Kidney Disease) induced ane...
Big benefits projected with SGLT2/RAAS inhibitor combination therapy
This study investigated the clinical characteristics and the risk factors for mortality in chronic kidney disease patients with tuberculosis.